RA Capital Management’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

RA Capital Management’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-9,011,651	Closed	-$180M	–	90
2022 Q3	$180M	Hold	9,011,651	–	–	3.84%	4
2022 Q2	$62.1M	Hold	9,011,651	–	–	1.66%	16
2022 Q1	$83.8M	Hold	9,011,651	–	–	1.83%	13
2021 Q4	$128M	Hold	9,011,651	–	–	2.26%	12
2021 Q3	$209M	Hold	9,011,651	–	–	2.9%	5
2021 Q2	$224M	Hold	9,011,651	–	–	3.6%	3
2021 Q1	$253M	Hold	9,011,651	–	–	3.81%	5
2020 Q4	$315M	Hold	9,011,651	–	–	4.4%	5
2020 Q3	$449M	Hold	9,011,651	–	–	8.22%	2
2020 Q2	$419M	Buy	+9,011,651	New	+$391M	8.16%	2

RA Capital Management's FMTX Position: Q4 2022 in Review

RA Capital Management sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 9,011,651 shares — an estimated $180M sold.

RA Capital Management first reported a position in FMTX in Q2 2020 and held it in 10 quarters. The position peaked at $449M in Q3 2020. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

RA Capital Management reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
RA Capital Management sold 9,011,651 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $180M.
RA Capital Management first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q2 2020 and held it in 10 quarters.
RA Capital Management's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $449M in Q3 2020.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on RA Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.